Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice

Area of Science:

• Immunology
• Vaccinology
• Microbiology

Background:

• Helicobacter pylori infection is a major cause of gastric diseases, including ulcers and cancer.
• Infection often occurs in early childhood, necessitating a vaccine for infants.
• Neonatal immune systems are considered immunologically privileged, posing challenges for vaccination.

Purpose of the Study:

• To investigate the efficacy of different Helicobacter pylori vaccine formulations and administration routes in neonatal mice.
• To determine if neonatal immunization can induce protective immunity comparable to adult immunization.

Main Methods:

• Neonatal and adult mice were immunized with H. pylori vaccine formulations using complete Freund's adjuvant (CFA) or incomplete Freund's adjuvant (IFA).
• Vaccines were administered via subcutaneous or intraperitoneal routes.
• Immune responses (T cell cytokine production) and protection against H. pylori challenge were assessed.

Main Results:

• Single-dose neonatal immunization with CFA induced robust T cell responses (IFN-γ, IL-2, IL-4, IL-5) similar to adult responses.
• Vaccination with either IFA or CFA via subcutaneous route provided partial protection against H. pylori challenge.
• Intraperitoneal immunization with CFA in neonates also reduced bacterial loads, with protection levels comparable to adults.

Conclusions:

• Neonatal immunization with H. pylori vaccines is feasible and can induce protective immunity.
• Different adjuvant and route combinations influence immune response and protection efficacy.
• These findings support the potential for early childhood vaccination to prevent H. pylori infection.